Formulation Development Applications & Studies

  1. A Human-Relevant Model Of The Liver Sinusoid 11/7/2024

    This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.

  2. Achieving Optimal CAR-T Cell Generation 10/9/2024

    Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.

  3. AAV Empty/Full Ratio Assessment Using The Octet® AAVX Biosensors 9/27/2024

    Learn about a rapid, high-throughput method for determining the E/F ratio in the AAV drug product that is well-suited for screening both crude and purified AAV samples.

  4. Rapid, Automated, At-Line Adenovirus Quantitation 9/27/2024

    Gain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.

  5. Lightning-Link® Conjugation Kits: Consistent Performance On A Broad Scale 9/26/2024

    Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.

  6. Leveraging Innovative Analytics To Ensure The Thermal Stability Of mAb Drug Products 9/23/2024

    Uncover how innovative Rapid Screening-Differential Scanning Calorimeter technology is enabling robust analysis and regulatory compliance by ensuring the thermal stability of antibody drug products.

  7. 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay 9/18/2024

    Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

  8. Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed 9/17/2024

    Explore results demonstrating the successful use of innovative ELISA assays to detect three key biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).

  9. High-Throughput 90-Minute ELISA 9/17/2024

    Discover how one solution can be utilized to measure Human IgG and human IFN gamma, which are key targets in pharmacokinetic studies and immunotherapeutic drug safety testing, in just 90 minutes.

  10. Fast And Accurate Detection Of Alzheimer's Disease Targets 9/17/2024

    In this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).